tirzepatide and visceral fat associated with a potential targeted effect on liver fat Retatrutide vs Tirzepatide: Triple agonist

Glutathione protects liver cells from damage caused by alcohol, drugs, and environmental toxins, and it also helps your liver grow new cells and regenerate healthy liver tissue

Studies indicate that 5-15% of participants experience mild nausea, typically occurring within 1-2 hours of administration

Progression of retinopathy with glucagon-like peptide-1 receptor agonists with cardiovascular benefits in type 2 diabetes - A systematic review and meta-analysis

Hepatic first-pass elimination (1 Fractional bioavailability) of Drug A is 60 % while that of Drug B is 40 %

TrkB, Tyrosine Receptor Kinase B

If your goal is to go all in on weight loss with the newest option and potentially stronger results, Tirzepatide could be the better fit